Katherine C. Kurnit
Expertise in
9
conditions

Dr. Katherine C. Kurnit

Obstetrics and Gynecology
14290 S. La Grange Rd., 
Orland Park, IL 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
9
conditions
14290 S. La Grange Rd., 
Orland Park, IL 

Overview

Katherine Kurnit is an Obstetrics and Gynecologist practicing medicine in Orland Park, Illinois.

Dr. Kurnit is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Ovarian Carcinosarcoma, Hysterectomy, and Oophorectomy.

Dr. Kurnit is board certified in Gynecologic Oncology, Practicing Since2011, and American Board Of Obstetrics Gynecology. She is actively involved in clinical research, co-authoring 52 peer reviewed articles and participating in 4 clinical trials. Dr. Kurnit is currently accepting new patients.

Specialties

Obstetrics and Gynecology

Licenses

Obstetrics & Gynecology in IL

Board Certifications

Gynecologic Oncology
Practicing Since2011
American Board Of Obstetrics Gynecology

Fellowships

MD Anderson Cancer Center

Hospital Affiliations

Ingalls Memorial Hospital
The University Of Chicago Medical Center
UChicago Medicine Faculty Physicians

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
MDwise
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

UChicago Medicine Orland Park
14290 S. La Grange Rd., Orland Park, IL 60462
Other Locations
Endeavor Health Medical Group
880 W. Central Rd., Suite 5000, Arlington Heights, IL 60005

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Assessment of Carboplatin Clearance Predictors: A PK Study on NCI-Sponsored Clinical Trials or Standard of Care Treatments Using Carboplatin
Assessment of Carboplatin Clearance Predictors: A PK Study on NCI-Sponsored Clinical Trials or Standard of Care Treatments Using Carboplatin
Enrollment Status: Active_not_recruiting
Publish Date: August 07, 2026
Intervention Type: Drug, Procedure
Study Phase: Phase 1
A Randomized Phase II Trial of Triplet Therapy (A PD-L1 Inhibitor Durvalumab (MEDI4736) in Combination With Olaparib and Cediranib) Compared to Olaparib and Cediranib or Durvalumab (MEDI4736) and Cediranib or Standard of Care Chemotherapy in Women With Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Primary Peritoneal or Fallopian Cancer Who Have Received Prior Bevacizumab
A Randomized Phase II Trial of Triplet Therapy (A PD-L1 Inhibitor Durvalumab (MEDI4736) in Combination With Olaparib and Cediranib) Compared to Olaparib and Cediranib or Durvalumab (MEDI4736) and Cediranib or Standard of Care Chemotherapy in Women With Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Primary Peritoneal or Fallopian Cancer Who Have Received Prior Bevacizumab
Enrollment Status: Active_not_recruiting
Publish Date: August 04, 2026
Intervention Type: Procedure, Drug, Biological
Study Drugs: Cediranib Maleate, Durvalumab, Olaparib, Paclitaxel, Pegylated Liposomal Doxorubicin Hydrochloride, Topotecan Hydrochloride
Study Phase: Phase 2
A Phase III Randomized Trial of Radiation +/- Pembrolizumab (MK-3475) for Newly Diagnosed Early Stage High Intermediate Risk Mismatch Repair Deficient (dMMR) Endometrioid Endometrial Cancer
A Phase III Randomized Trial of Radiation +/- Pembrolizumab (MK-3475) for Newly Diagnosed Early Stage High Intermediate Risk Mismatch Repair Deficient (dMMR) Endometrioid Endometrial Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 02, 2026
Intervention Type: Other, Procedure, Radiation, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 3
A Phase 1b/2, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients With Solid Tumors Likely to Express NaPi2b
A Phase 1b/2, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients With Solid Tumors Likely to Express NaPi2b
Enrollment Status: Active_not_recruiting
Publish Date: November 13, 2023
Intervention Type: Drug
Study Drug: Upifitamab rilsodotin
Study Phase: Phase 1/Phase 2
View 3 Less Clinical Trials

52 Total Publications

Feedback activation of MAPK-ERK1/2 signaling causes resistance to trastuzumab-deruxtecan in endometrial cancers.
Feedback activation of MAPK-ERK1/2 signaling causes resistance to trastuzumab-deruxtecan in endometrial cancers.
Journal: Gynecologic oncology
Published: April 07, 2026
Similar Doctors
Expertise in
12
conditions
Dr. John W. Moroney
Obstetrics and Gynecology
Expertise in
12
conditions
Dr. John W. Moroney
Obstetrics and Gynecology
Referral may be required
Before you request

UChicago Medicine Orland Park

14290 S. La Grange Rd., 
Orland Park, IL 
 (0.1 miles away)
888-824-0200
Languages Spoken:
English, Turkish
See accepted insurances
Accepting New Patients
Offers Telehealth

John Moroney is an Obstetrics and Gynecologist practicing medicine in Orland Park, Illinois. Dr. Moroney is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Sertoli-Leydig Cell Tumor, Gastrostomy, and Bladder Reconstruction. Dr. Moroney is board certified in Gynecologic Oncology, American Board Of Obstetrics Gynecology, and Practicing Since2002. Dr. Moroney is currently accepting new patients.

Expertise in
10
conditions
Dr. Gary H. Altwerger
Obstetrics and Gynecology
Expertise in
10
conditions
Dr. Gary H. Altwerger
Obstetrics and Gynecology
Referral may be required

UChicago Medicine Orland Park

14290 S. La Grange Rd., 
Orland Park, IL 
 (0.1 miles away)
888-824-0200
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Gary Altwerger is an Obstetrics and Gynecologist practicing medicine in Orland Park, Illinois. Dr. Altwerger is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Ovarian Carcinosarcoma, Ovarian Cancer, Endometrial Cancer, Hormone Replacement Therapy (HRT), and Hysterectomy.

Expertise in
16
conditions
Dr. Sudarshan K. Sharma
Obstetrics and Gynecology
Expertise in
16
conditions
Dr. Sudarshan K. Sharma
Obstetrics and Gynecology
Referral may be required

UChicago Medicine Duchossois Center For Advanced Medicine - Hyde Park

5758 S. Maryland Ave., 
Chicago, IL 
 (16.9 miles away)
888-824-0200
Languages Spoken:
English, Hindi, Punjabi, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Sudarshan Sharma is an Obstetrics and Gynecologist practicing medicine in Chicago, Illinois. Dr. Sharma is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Sertoli-Leydig Cell Tumor, Oophorectomy, and Lymphadenectomy. Dr. Sharma is currently accepting new patients.

Frequently Asked Questions about Dr. Katherine C. Kurnit

How do I make an appointment with Dr. Katherine C. Kurnit?

You can book an appointment with Dr. Katherine C. Kurnit by calling their office at 888-824-0200. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Katherine C. Kurnit a top-rated expert for Endometrial Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Katherine C. Kurnit is classified as an Distinguished expert for Endometrial Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Katherine C. Kurnit specialize in?

While Dr. Katherine C. Kurnit is a Obstetrics and Gynecology, they have specific expertise in Endometrial Cancer, Ovarian Cancer, and Ovarian Carcinosarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Obstetrics and Gynecology.

Does Dr. Katherine C. Kurnit participate in research or clinical trials?

Yes. Dr. Katherine C. Kurnit has published 52 articles and abstracts on conditions like Endometrial Cancer. You can view a list of Dr. Katherine C. Kurnit's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Katherine C. Kurnit accept my insurance?

Dr. Katherine C. Kurnit accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 888-824-0200 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kurnit's expertise for a condition
ConditionClose
    View All 10 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile